This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1r5y

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /><applet load="1r5y" size="450" color="white" frame="true" align="right" spinBox="true" caption="1r5y, resolution 1.20&Aring;" /> '''Crystal Structure of...)
Line 1: Line 1:
-
[[Image:1r5y.jpg|left|200px]]<br /><applet load="1r5y" size="450" color="white" frame="true" align="right" spinBox="true"
+
[[Image:1r5y.jpg|left|200px]]<br /><applet load="1r5y" size="350" color="white" frame="true" align="right" spinBox="true"
caption="1r5y, resolution 1.20&Aring;" />
caption="1r5y, resolution 1.20&Aring;" />
'''Crystal Structure of TGT in complex with 2,6-Diamino-3H-Quinazolin-4-one Crystallized at PH 5.5'''<br />
'''Crystal Structure of TGT in complex with 2,6-Diamino-3H-Quinazolin-4-one Crystallized at PH 5.5'''<br />
==Overview==
==Overview==
-
The enzyme tRNA-guanine transglycosylase (TGT) is involved in the, pathogenicity of Shigellae. As the crystal structure of this protein is, known, it is a putative target for the structure-based design of, inhibitors. Here we report a crystallographic study of several new ligands, exhibiting a 2,6-diamino-3H-quinazolin-4-one scaffold, which has been, shown recently to be a promising template for TGT-inhibitors. Crystal, structure analysis of these complexes has revealed an unexpected movement, of the side-chain of Asp102. A detailed analysis of the water network, disrupted by this rotation has lead to the derivation of a new composite, pharmacophore. A virtual screening has been performed based on this, pharmacophore hypothesis and several new inhibitors of micromolar binding, affinity with new skeletons have been discovered.
+
The enzyme tRNA-guanine transglycosylase (TGT) is involved in the pathogenicity of Shigellae. As the crystal structure of this protein is known, it is a putative target for the structure-based design of inhibitors. Here we report a crystallographic study of several new ligands exhibiting a 2,6-diamino-3H-quinazolin-4-one scaffold, which has been shown recently to be a promising template for TGT-inhibitors. Crystal structure analysis of these complexes has revealed an unexpected movement of the side-chain of Asp102. A detailed analysis of the water network disrupted by this rotation has lead to the derivation of a new composite pharmacophore. A virtual screening has been performed based on this pharmacophore hypothesis and several new inhibitors of micromolar binding affinity with new skeletons have been discovered.
==About this Structure==
==About this Structure==
-
1R5Y is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Zymomonas_mobilis Zymomonas mobilis] with ZN and DQU as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Queuine_tRNA-ribosyltransferase Queuine tRNA-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.29 2.4.2.29] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1R5Y OCA].
+
1R5Y is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Zymomonas_mobilis Zymomonas mobilis] with <scene name='pdbligand=ZN:'>ZN</scene> and <scene name='pdbligand=DQU:'>DQU</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Queuine_tRNA-ribosyltransferase Queuine tRNA-ribosyltransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.4.2.29 2.4.2.29] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1R5Y OCA].
==Reference==
==Reference==
Line 15: Line 15:
[[Category: Zymomonas mobilis]]
[[Category: Zymomonas mobilis]]
[[Category: Brenk, R.]]
[[Category: Brenk, R.]]
-
[[Category: Garcia, G.A.]]
+
[[Category: Garcia, G A.]]
[[Category: Klebe, G.]]
[[Category: Klebe, G.]]
[[Category: Meyer, E.]]
[[Category: Meyer, E.]]
[[Category: Reuter, K.]]
[[Category: Reuter, K.]]
-
[[Category: Stubbs, M.T.]]
+
[[Category: Stubbs, M T.]]
[[Category: DQU]]
[[Category: DQU]]
[[Category: ZN]]
[[Category: ZN]]
[[Category: transferase]]
[[Category: transferase]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 01:17:32 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:47:31 2008''

Revision as of 12:47, 21 February 2008


1r5y, resolution 1.20Å

Drag the structure with the mouse to rotate

Crystal Structure of TGT in complex with 2,6-Diamino-3H-Quinazolin-4-one Crystallized at PH 5.5

Overview

The enzyme tRNA-guanine transglycosylase (TGT) is involved in the pathogenicity of Shigellae. As the crystal structure of this protein is known, it is a putative target for the structure-based design of inhibitors. Here we report a crystallographic study of several new ligands exhibiting a 2,6-diamino-3H-quinazolin-4-one scaffold, which has been shown recently to be a promising template for TGT-inhibitors. Crystal structure analysis of these complexes has revealed an unexpected movement of the side-chain of Asp102. A detailed analysis of the water network disrupted by this rotation has lead to the derivation of a new composite pharmacophore. A virtual screening has been performed based on this pharmacophore hypothesis and several new inhibitors of micromolar binding affinity with new skeletons have been discovered.

About this Structure

1R5Y is a Single protein structure of sequence from Zymomonas mobilis with and as ligands. Active as Queuine tRNA-ribosyltransferase, with EC number 2.4.2.29 Full crystallographic information is available from OCA.

Reference

Crystallographic study of inhibitors of tRNA-guanine transglycosylase suggests a new structure-based pharmacophore for virtual screening., Brenk R, Meyer EA, Reuter K, Stubbs MT, Garcia GA, Diederich F, Klebe G, J Mol Biol. 2004 Apr 16;338(1):55-75. PMID:15050823

Page seeded by OCA on Thu Feb 21 14:47:31 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools